Effects of <scp>l‐c</scp>arnitine on frailty status in patients with liver cirrhosis: A randomized‐controlled trial
In conclusion, the administration of l-carnitine exhibited hepatoprotective properties and was correlated with lowered alanine transaminase levels with improvement in coagulation status in liver cirrhosis patients. Nevertheless, our study indicated that the short-term use of l-carnitine might not significantly improve frailty in these patients.
Authors
- Ahad Eshraghian (ORCID: https://orcid.org/0000-0003-0751-5712)
- Nasrin Motazedian (ORCID: https://orcid.org/0000-0001-9534-4014)
- Sarina Pourjafar
- Anita Ashari
- Niloofar Dehdari Ebrahimi (ORCID: https://orcid.org/0000-0002-9866-8361)
- Alireza Shamsaeefar (ORCID: https://orcid.org/0000-0003-3798-6064)
- Mehrab Sayadi
- Vahid Khademi
Institutions
- Shiraz University of Medical Sciences (IR)
- Jahrom University (IR)
- Jahrom University of Medical Sciences (IR)
Publication Details
- Journal
- Health Science Reports
- Published
- 2024-10-27
- DOI
- https://doi.org/10.1002/hsr2.70148
- Citations
- 1
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.37
Funders
- Shiraz University of Medical Sciences